Stocks Hitting 52-Week Highs

Brainstorm Cell Therapeutics Inc. BCLI shares reached a new 52-week high of $7.48 ahead of January 5 conference call to discuss final results of Phase 2a trial of NurOwn in ALS. Cnova N.V. CNV shares rose 4.99% to touch a new 52-week high of $8.30. Analysts at Credit Suisse initiated coverage on Cnova with a Outperform rating. Quest Diagnostics Inc. DGX shares gained 3.21% to touch a new 52-week high of $69.21. Raymond James upgraded Quest Diagnostics from Underperform to Market Perform. Laboratory Corp. of America Holdings LH shares reached a new 52-week high of $112.25. Analysts at Raymond James upgraded Laboratory Corp. of America Holdings from Underperform to Outperform.